National Journal of Physiology

Register      Login

VOLUME 4 , ISSUE 2 ( July-December, 2016 ) > List of Articles

CASE REPORT

A case of acquired amegakaryocytic thrombocytopenic purpura

Suzanne Maria D cruz, Selvam MD, Navin Rajaratnam, Pratheep Raj

Keywords : acquired amegakaryocytic thrombocytopenic purpura, megakaryocytes, platelets, thrombocytopenia

Citation Information : D cruz SM, MD S, Rajaratnam N, Raj P. A case of acquired amegakaryocytic thrombocytopenic purpura. 2016; 4 (2):42-45.

DOI: 10.5005/NJP-11056-04_02_08

License: CC BY-NC 4.0

Published Online: 01-12-2016

Copyright Statement:  Copyright © 2016; NA


Abstract

Acquired amegakaryocytic thrombocytopenic purpura (AATP) is characterized by decreased or absent megakaryocytes in an otherwise normal bone marrow and is a rare cause of thrombocytopenia. We report a case of a 39-year-old woman, who was admitted to a tertiary care hospital for platelet transfusions. She gave history of severe recurrent epistaxis, pupura, bleeding gums and menorrhagia for the past four years, for which she had been investigated in various medical centers. She was eventually diagnosed as having acquired amegakaryocytic thrombocytopenia; her bone marrow study revealed a normocellular marrow with absent megakaryocytes and no abnormal cells; and she was advised an allogeneic peripheral blood stem cell transplant. We report this rare cause of thrombocytopenia in view of its potential interest to physiologists and we also review the literature regarding its pathogenesis and treatment.


PDF Share
PDF Share
  1. Greer JP, Arber DA, Glader B, List AF, Means RT Jr, Paraskevas F, Rodgers GM, eds. Wintrobe's clinical hematology. 13th edition. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins Health; 2014.
  2. Brown GE, Babiker HM, Cantu CL, Yeager AM, Krishnadasan R. “Almost bleeding to death”: the conundrum of acquired amegakaryocytic thrombocytopenia. Case Rep Hematol. 2014; 2014:806541.
  3. Lown R, Rhodes E, Bosworth J, Shannon MS, Stasi R. Acquired amegakaryocytic thrombocytopenia: Potential role of thrombopoietin receptor agonists. Clin Adv Hematol Oncol. 2010;8:809-812
  4. Harjai K, Shah M, Pant A, Kale P, Pathare A V. Amegakaryocytic thrombocytopenic purpura. J Postgrad Med. 1992;38:96.
  5. Patel S, Shashidhar B, Kruthika N, Nataraju HV, Vedavathi R, Pradeep C. A rare case of thrombocytopenia - Acquired amegakaryocytic aplasia. USS Case Reports & Reviews 2015;l(ll):73.
  6. Betdur AL, Bhagra A, Krishna Tej CH, Ponnambalam R, Somasekar DS. An unusual case of Amegakaryocytic Thrombocytopenia. Journal of Evidence based Medicine and Healthcare 2014; 1(17): 2222-26.
  7. Lonial S, Bilodeau PA, Langston AA, Lewis C, Mossavi-Sai S, Holden JT, Waller EK. Acquired amegakaryocytic thrombocytopenia treated with allogeneic BMT: a case report and review of the literature. Bone Marrow Transplant 1999;24 (12):1337-41.
  8. Cela I, Miller IJ, Katz RS, Rizman A, Shamma JM. Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE). Clin Adv Hematol Oncol. 2010;8(ll):806-9.
  9. Shigekiyo T, Sekimoto E, Shibata H, Ozaki S, Fujinaga H, Hirose T. Treatment of acquired amegakaryocytic thrombocytopenic purpura with romiplostim. Platelets 2015; 26:504-506.
  10. Agarwal N, Spahr JE, Werner TL, Newton DL, Rodgers GM. Acquired amegakaryocytic thrombocytopenic purpura. Am J Hematol 2006; 81:132-5.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.